2021
DOI: 10.1016/j.addr.2021.114027
|View full text |Cite
|
Sign up to set email alerts
|

Nanomedicine from amphiphilized prodrugs: Concept and clinical translation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
30
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 231 publications
0
30
0
Order By: Relevance
“…Thus, the polymerization of BPA-NCA proceeded at 80 °C as follows. 1 H NMR of PEG-PBPA (M n = 5.0−4.0 kg/mol) presented characteristic signal peaks of PEG (δ 3.51) and BPA (δ 7.68, 7.22) (Figure ). According to the integral intensities of characteristic signal peaks of PEG and BPA, the degree of polymerization (DP) of BPA was calculated to be 21, which was in line with the theoretical design.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Thus, the polymerization of BPA-NCA proceeded at 80 °C as follows. 1 H NMR of PEG-PBPA (M n = 5.0−4.0 kg/mol) presented characteristic signal peaks of PEG (δ 3.51) and BPA (δ 7.68, 7.22) (Figure ). According to the integral intensities of characteristic signal peaks of PEG and BPA, the degree of polymerization (DP) of BPA was calculated to be 21, which was in line with the theoretical design.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…48,49 Notably, according to their molecular weights, amphiphilic prodrugs could be broadly divided into two categories, namely polymer–drug conjugates ((poly)-prodrug amphiphiles) and drug–drug conjugates (amphiphilized homo/heterodimeric prodrugs). 50 As illustrated in Fig. 1C, the amphiphilic polymer–drug conjugates were synthesized by attaching single or multiple parent drugs onto carrier materials of synthetic (block polymers) or biological origin (peptides or oligonucleotides) via covalent stimulus-labile linkages.…”
Section: Concept and Design Of Prodrug Nanoassembliesmentioning
confidence: 99%
“…Prodrug design provides a useful strategy for overcoming these drawbacks. [1][2][3][4] One of the efforts in the past few decades has been focused on developing polymer and macromolecule-based prodrugs that decrease first-pass elimination in the kidneys and improve selective accumulation in tumours via the enhanced permeation and retention effect (EPR). [4][5][6][7][8][9] Among others, the dynamic hydrazone bond has been demonstrated as an efficient tool to conjugate drugs to produce various polymeric and macromolecular prodrugs, [9][10][11][12] which release active agents via acid-responsive hydrolysis in the tumour microenvironment.…”
Section: Introductionmentioning
confidence: 99%